01 — At a Glance
The Mansion House Comes Home With a Roommate Named Imperial Blue
- 52-Week High / Low₹550 / ₹200
- Q3 FY26 Revenue (Consolidated)₹664 Cr
- Q3 FY26 PAT (Consolidated)-₹105 Cr*
- Q3 FY26 EPS (Consolidated)-₹4.26
- FY25 Full-Year EPS₹11.86
- Book Value₹80.6
- Price to Book5.56x
- Dividend Yield0.22%
- Debt / Equity0.02x
- Imperial Blue Deal Value₹3,442 Cr
The Context: Tilaknagar swallowed India’s second-largest whisky brand (Imperial Blue) on December 1, 2025, after Pernod Ricard quietly gave up the ghost. Q3 revenue exploded +95% YoY, but ₹169 crore in exceptional costs (transaction fees, TSMA charges, consultant bills) wiped out profitability on paper. Strip away the one-time noise, and you find a company that’s suddenly India’s largest prestige+ spirits player with 32% market share in the combined biz. The stock’s at ₹445, P/E shows 38.9x (based on pre-acquisition FY25 earnings of ₹11.86). This is either a genius consolidation play or the world’s most expensive integration headache. Spoiler: probably both.
02 — Introduction
The Brandy King Just Went Aquaman: Whisky Edition
Tilaknagar Industries. Been around since 1858 — yes, the year they invented the light bulb. The company built a fortress selling Mansion House Brandy, which is India’s largest-selling brandy and the second-largest globally (after Cognac). Not bad for a South India–focused player with 86% of sales historically coming from below the Vindhyas.
Then in December 2025, someone at Pernod Ricard HQ decided Imperial Blue — India’s fastest-growing whisky, the cool kid in the bottle — wasn’t “strategic” anymore. (Translation: bleeding cash, needs management discipline Pernod couldn’t deliver from France.) So they put it up for sale.
Tilaknagar stepped in with ₹3,442 crore, borrowed ₹2,100 crore from banks, and suddenly transformed from a regional brandy powerhouse into a national multi-category play. In December alone (post-acquisition), they combined to move 2.1 million cases and grabbed 32% prestige-+ market share in Southern India. That’s not a business update. That’s a power grab.
But here’s the rub: the deal closed in Q3, so only 1 month of Imperial Blue figures hit the P&L (December 2025). Q3 FY26 PAT shows -₹105 crore because ₹169 crore went to transaction costs. Next quarter onwards, you’re seeing the real business. And that’s why everyone’s screaming — or sobbing — into their spreadsheets.
Management Goldmine (Feb 2026 Concall): “TI became the largest prestige and above IMFL player with 32% market share… restoring Imperial Blue to leadership and making it India’s largest-selling whisky.” A statement so bold it should be framed. We’ll validate it by Q4 FY26.
03 — Business Model: WTF Is Even the Company Now?
Brandy + Whisky + Ambition = Risk Squared
Pre-acquisition (TI standalone), it was dead simple: buy grain/molasses, distill, add the Mansion House label, distribute through 40,000+ outlets across South India. Brandy accounted for 94% of revenues. ROE 29.6%, ROCE 28.2%. A boring cash machine that the Southern investor class loved.
Post-acquisition (Dec 2025 onwards), it’s a two-brand, two-category sprawl:
Mansion House Brandy (TI’s Core): 11.91 mn cases sold in FY25. NSR (net sales realization) per case: ₹1,214. Growing steadily. Owns 94%+ of India’s brandy volumes. No one’s touching this throne.
Imperial Blue Whisky (New Addition): Acquired with ~₹400 crore annual revenue pre-acquisition. Moved 1.8 mn cases in December alone under TI’s stewardship. Management claims they’ll push this into India’s largest-selling whisky position (currently ~3rd–4th, behind Royal Challenge and Officer’s Choice). The upside is real; the execution risk is, err, also real.
Distribution: 40,000 outlets inherited, now with access to 7.09% stake in Ki Mobility (EV after-sales services — a 5-year bet), 10-year pact to make Pernod Ricard products, and partnerships with Spaceman Spirits Lab (gin/vodka brands). The playbook is distribution thickness — make yourself indispensable at every alcohol outlet from Kashmir to Kanyakumari.
💬 Real talk: Does Tilaknagar have the operational chops to restore Imperial Blue’s mojo, or will this turn into a ₹3,442 crore “oops, we overpaid” story? Drop your verdict in the comments.
04 — Financials Overview
Q3 FY26: The Numbers (and the Asterisks)
Continue reading with a premium membership.
